News

‘Clusters’ of immune cells are associated with advanced stomach cancers, but they provide few clinical or prognostic clues for these tumours, a new Hudson Institute study has found. Professor Brendan Jenkins, the study’s co-author, says that in some other cancers, the presence of these clusters, called immune cell aggregates, indicates improved patient survival – but…  Read more

Congratulations to our PhD students who presented their exceptional research at this year’s Hudson Institute/SCS Three Minute Thesis (3MT) competition final on Wednesday, 4 July. The Three Minute Thesis (3MT™) is a national research communication competition that celebrates exciting research conducted by PhD research students. Students have three minutes to present a compelling oration on…  Read more

PhD student, Anqi Li has been selected to take part in the prestigious SPARK Biomedical Innovation and Entrepreneurship training course in Berlin, Germany this month. The two-week intensive course aims to bridge the gap between industry and academia by helping PhD students to think in creative, innovative and entrepreneurial ways.  It is part of the…  Read more

A new gene that plays a critical role in regulating the body’s immune response to infection and disease has been identified. The discovery could lead to the development of new treatments for influenza, arthritis and even cancer. Dr Rebecca Ambrose, now a Hudson Institute postdoctoral scientist, was part of the CSIRO team that discovered the…  Read more

A new brain imaging study has shown how snoring, or sleep disordered breathing, in children may lead to changes in parts of the brain that control blood pressure, learning and behaviour – and should be treated as early as possible. The findings of the study led by Professor Rosemary Horne’s team in The Ritchie Centre,…  Read more

The Active Ratio Test represents an exciting step forward in innovative ovarian cancer research. Should it be successful, a test as simple as taking a swab or blood sample will result in the early detection of ovarian cancer in women who otherwise exhibit no symptoms. Vague and misleading symptoms, combined with the need for invasive…  Read more

A new PhD scholars program in paediatric cancer precision medicine has been established at Hudson Institute of Medical Research with co-funding from the Children’s Cancer Foundation. The program will train the next generation of scientists in advanced functional and structural genomics, development of patient-centric preclinical models, bioinformatics analytics and translational research with the aim of…  Read more

Congratulations to Professor Rosemary Horne, who has received the Distinguished Researcher Award for 2018 at the meeting of the International Society for the Study and Prevention of Infant and Neonatal Death in Glasgow last week. The award is made for outstanding contributions to research in the area of sudden unexpected death in infancy research as evidenced…  Read more

Research leading to improved outcomes for babies with congenital diaphragmatic hernia was the focus of a community forum last month in Melbourne. The Fetal Therapy Research Group, led by Associate Professor Ryan Hodges, is working towards improving outcomes for babies who have difficulty breathing at birth due to a condition called congenital diaphragmatic hernia (CDH).…  Read more

Professor Kate Lovelannd has been named the 2018 recipient of the Society for the Study of Reproduction (SSR) Fuller W. Bazer International Scientist Award. Prof Loveland is an international leader in male reproductive health research. She is Head of the Centre for Reproductive Health at Hudson Institute and Head of Postgraduate Studies, School of Clinical…  Read more